MDR-001 progressed from program discovery to Phase III in just 4.5 years, much faster than traditional development cycles.Phase IIb data ...

A live webcast of the event will be available in the Investors section of the Maze Therapeutics website at www.mazetx.com and ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...

Tv Therapeutics (VTVT) is a $156 million biopharma focused on small molecule drugs for Alzheimer’s, diabetes, and ...

Small Molecule CMO/CDMO Market Report On Size, Share, Competitive Landscape, And Trends Analysis. EINPresswire/ -- The small molecule CMO/CDMO sector is experiencing robust growth fueled by evolving ...

The modulation of RNA splicing by small molecules has emerged as a promising strategy for treating pathogenic infections, human genetic diseases, and cancer; however, the principles by which splicing ...

WASHINGTON, DC - AUGUST 16: U.S. President Joe Biden (C) signs The Inflation Reduction Act with Senate Majority Leader Charles Schumer (D-NY) (L) and House Majority Whip James Clyburn (D-SC) in the ...

Researchers have converted an existing cancer drug into a molecule that selectively targets a cancer-associated ribonucleic acid (RNA) for destruction. This molecule, a ribonuclease targeting chimera, ...

In opposing a fix to the 2022 Inflation Reduction Act, a leading voice in the effort to move the U.S. biopharmaceutical system toward European-style price controls cited “complicated details” in his ...

The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability ...